Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic HIV infection: the randomized non-inferiority MONCAY trial.
暂无分享，去创建一个
F. Raffi | J. Parienti | L. Hocqueloux | L. Bernard | V. Avettand-Fenoel | T. Prazuck | D. Rey | C. Allavena | E. Billaud | G. Le Moal | A. Valéry | S. Sunder | M. Roncato-Sabéran | J. Esnault | M. André